342 related articles for article (PubMed ID: 31998632)
21. A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura.
Mittal S; Blaylock MG; Culligan DJ; Barker RN; Vickers MA
Haematologica; 2008 Jan; 93(1):151-2. PubMed ID: 18166805
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune complications of chronic lymphocytic leukemia.
Hamblin TJ
Semin Oncol; 2006 Apr; 33(2):230-9. PubMed ID: 16616070
[TBL] [Abstract][Full Text] [Related]
23. B cells CD19+ in patients with B-cell chronic lymphocytic leukaemia and autoimmune haemolytic anaemia.
Słomkowski M; Kopeć-Szlezak J; Fabijańska-Mitek J; Podstawka U; Sikorska A; Mendek-Czajkowska E
Clin Lab Haematol; 2004 Dec; 26(6):385-9. PubMed ID: 15595995
[TBL] [Abstract][Full Text] [Related]
24. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia.
Pritsch O; Maloum K; Dighiero G
Semin Oncol; 1998 Feb; 25(1):34-41. PubMed ID: 9482525
[TBL] [Abstract][Full Text] [Related]
25. Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review.
Fattizzo B; Zaninoni A; Giannotta JA; Binda F; Cortelezzi A; Barcellini W
Autoimmun Rev; 2016 Jul; 15(7):770-5. PubMed ID: 26988993
[TBL] [Abstract][Full Text] [Related]
26. A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D.
Fukatsu M; Hamazaki Y; Sato Y; Koyama D; Ikezoe T
Int J Hematol; 2023 Oct; 118(4):472-476. PubMed ID: 37133636
[TBL] [Abstract][Full Text] [Related]
27. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
28. Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.
Hauswirth AW; Skrabs C; Schützinger C; Gaiger A; Lechner K; Jäger U
Leuk Lymphoma; 2007 Jun; 48(6):1139-49. PubMed ID: 17577777
[TBL] [Abstract][Full Text] [Related]
29. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.
Visco C; Maura F; Tuana G; Agnelli L; Lionetti M; Fabris S; Novella E; Giaretta I; Reda G; Barcellini W; Baldini L; Neri A; Rodeghiero F; Cortelezzi A
Clin Cancer Res; 2012 Apr; 18(7):1870-8. PubMed ID: 22322667
[TBL] [Abstract][Full Text] [Related]
30. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune Complications in Hematologic Neoplasms.
Barcellini W; Giannotta JA; Fattizzo B
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810369
[TBL] [Abstract][Full Text] [Related]
32. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
33. Chronic Lymphocytic Leukemia Presenting as a Subcortical Watershed Infarct.
Gupta M; Singh D; Lee P; Kadiyam S
Case Rep Hematol; 2019; 2019():2089359. PubMed ID: 30729050
[TBL] [Abstract][Full Text] [Related]
34. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of immunological tolerance loss versus erythrocyte self-antigens and autoimmune hemolytic anemia.
Fagiolo E; Toriani-Terenzi C
Autoimmunity; 2003 Jun; 36(4):199-204. PubMed ID: 14563012
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
[TBL] [Abstract][Full Text] [Related]
37. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
Strati P; Caligaris-Cappio F
Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
[TBL] [Abstract][Full Text] [Related]
38. Successful Long-Term Use of Eltrombopag in a Patient with Refractory Severe Thrombocytopenia Associated with Chronic Lymphocytic Leukemia That Allowed Oral Anticoagulant Treatment for Severe Cardiomyopathy.
Luis Miguel JS; Juan José GF
Case Rep Hematol; 2017; 2017():9538920. PubMed ID: 28469947
[TBL] [Abstract][Full Text] [Related]
39. Small molecule phagocytosis inhibitors for immune cytopenias.
Neschadim A; Kotra LP; Branch DR
Autoimmun Rev; 2016 Aug; 15(8):843-7. PubMed ID: 27296447
[TBL] [Abstract][Full Text] [Related]
40. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders.
Pavkovic M; Georgievski B; Cevreska L; Spiroski M; Efremov DG
Am J Hematol; 2003 Feb; 72(2):147-9. PubMed ID: 12555221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
